title: Development of Crescentic Immunoglobulin A Nephritis and Multiple Autoantibodies in a Patient during Adalimumab Treatment for Rheumatoid Arthritis.
authors.forename: Xia
authors.initials: X
authors.lastname: Li
authors.affiliation: Renal Division, Department of Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing 100730, China.
authors.forename: Jie
authors.initials: J
authors.lastname: Ma
authors.forename: Yan
authors.initials: Y
authors.lastname: Zhao
authors.forename: Hai-Yun
authors.initials: HY
authors.lastname: Wang
authors.forename: Xue-Mei
authors.initials: XM
authors.lastname: Li
mesh_terms: D000068879:Adalimumab / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology*; D044466:Asian People; D001323:Autoantibodies / Q000276:immunology*; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology*; D008875:Middle Aged; D009393:Nephritis / Q000209:etiology* / Q000276:immunology*
chemical_list: D018501:Antirheumatic Agents; D001323:Autoantibodies; D007070:Immunoglobulin A; D000068879:Adalimumab